New hope for Tough-to-Treat lung cancer: first patients test novel drug

NCT ID NCT06343402

Recruiting now Disease control Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) Source: ClinicalTrials.gov ↗

Summary

This is the first study in people to test a new drug called BBO-8520 for advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. The main goals are to find a safe dose and see if the drug can help shrink tumors. The study will test BBO-8520 alone and in combination with other cancer drugs in about 350 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States
Flinders Medical Centre
RECRUITING

Bedford Park, South Australia, 5042, Australia
Fred Hutchinson Cancer Center
RECRUITING

Seattle, Washington, 98109, United States
Henry Ford Cancer - Detroit
RECRUITING

Detroit, Michigan, 48282, United States
Huntsman Cancer Institute
RECRUITING

Salt Lake City, Utah, 84112, United States
Jewish General Hospital
RECRUITING

Montreal, Quebec, H3T 1E2, Canada
Juravinski Cancer Centre
RECRUITING

Hamilton, Ontario, L8V 5C2, Canada
Kinghorn Cancer Centre
RECRUITING

Darlinghurst, New South Wales, 2010, Australia
Linear Clinical Research
RECRUITING

Nedlands, Western Australia, 6009, Australia
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
NEXT Oncology
RECRUITING

Fairfax, Virginia, 22031, United States
Northwest Medical Specialties
RECRUITING

Tacoma, Washington, 98405, United States
Norwalk Hospital
RECRUITING

Norwalk, Connecticut, 06850, United States
O'Neal Comprehensive Cancer Center at UAB
RECRUITING

Birmingham, Alabama, 35233, United States
OSF Saint Francis Medical Center
RECRUITING

Peoria, Illinois, 61603, United States
Oncology Consultants Texas Medical Center
RECRUITING

Houston, Texas, 77030, United States
Peninsula & South Eastern Hematology and Oncology Group (PAS)
RECRUITING

Frankston, Victoria, 3199, Australia
Perlmutter Cancer Center - NYU Langone Health
RECRUITING

New York, New York, 10016, United States
Peter MacCallum Cancer Centre
RECRUITING

Melbourne, Victoria, 3051, Australia
Roswell Park Cancer Institute
RECRUITING

Buffalo, New York, 14263, United States
SCRI Oncology Partners
RECRUITING

Nashville, Tennessee, 37203, United States
The Princess Margaret Cancer Centre
RECRUITING

Toronto, Ontario, M5G 2C4, Canada
The Queen Elizabeth Hospital
RECRUITING

Woodville South, South Australia, 5011, Australia
UCLA Health - Santa Monica Cancer Care
RECRUITING

Santa Monica, California, 90404, United States
USOR - Oncology Associates of Oregon, P.C
RECRUITING

Eugene, Oregon, 97401, United States
USOR - Texas Oncology - (DFW) Waco
RECRUITING

Waco, Texas, 76710, United States
University of California - San Diego Moores Cancer Center
RECRUITING

La Jolla, California, 92093, United States
University of California San Francisco
RECRUITING

San Francisco, California, 94158, United States
University of Colorado Cancer Center
RECRUITING

Aurora, Colorado, 80045, United States
University of Kansas Medical Center
RECRUITING

Kansas City, Kansas, 66205, United States
Yale Cancer Center
RECRUITING

New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED LUNG CARCINOMA KRAS G12C METASTATIC LUNG CANCER METASTATIC NON-SMALL CELL LUNG CANCER NON SMALL CELL LUNG CANCER NSCLC